Visit https://www.peervoice.com/AHQ860 to view the entire programme with slides. After completing “Going Below the Surface in Advanced Basal Cell Carcinoma: Analysing the Latest Evidence”, participants will be able to: Describe the role of immunotherapy options for advanced BCC; Evaluate the most current clinical evidence for these options in terms of efficacy and safety; and Describe the clinical implications of these options on the treatment paradigm for advanced BCC, from an interdisciplinary perspective.

Early Disease Control in Inflammatory Bowel Disease: Integrating the Latest Evidence for Better Outcomes

Challenging the Standard of Care in First-Line Advanced HCC Treatment: Breakthroughs With Immunotherapy

Managing Youth-Onset Type 2 Diabetes: What Paediatricians Need to Know

Making the Case for Personalized Management in mCSPC: Pertinent Characteristics to Choose the Right Therapy

Exploring Early LDL-C Lowering in Patients With Recent MI to Reduce Risk of Future Events

"Screening and Early Management of Metastatic NSCLC: Updatesto Optimize Multidisciplinary Care"

Patient Scenarios in Rheumatoid Arthritis: Optimising Remission With JAK Inhibitors

Managing Patients With Hemophilia A Without Inhibitors in the Era of Non-Replacement Therapy: The Experts Weigh In

Defining a Patient-Centred Approach to Non-Metastatic Castration-Resistant Prostate Cancer